![]() |
||||||
|
||||||
![]() |
||||||
| About Us >> Management |
| Management | |||||||||||||||||||||||||
|
Rare Dedication from Management Who Shares the MissionSigma-Tau Pharmaceuticals, Inc. is managed by a team of seasoned pharmaceutical executives who have all come together for the same reason—to help people with rare diseases. By coalescing their vast and diverse professional and personal experiences, Sigma-Tau is able to discover and distribute important, needed therapies to patients with rare diseases. |
||||||||||||||||||||||||
![]() |
Gregg
Lapointe, MBA Chief Executive Officer |
![]() |
Gianfranco
Fornasini, PhD Senior Vice President, Scientific Affairs |
||||||||||||||||||||||
![]() |
Warren
J. Holmes Vice President, Organizational Services |
![]() |
Taha
Keilani, MD Vice President, Clinical Affairs |
||||||||||||||||||||||
![]() |
Brian
Schreiber, MD Vice President, Medical Affairs |
![]() |
Marc
Tewey, MBA Vice President, Commercial Operations |
||||||||||||||||||||||
![]() |
Don
DeLillo Director, Finance |
![]() |
Yamil
Hernandez, MBA Director, Business Development |
||||||||||||||||||||||
![]() |
Nancy
Klett, MPH Director, Human Resources |
hello |
|||||||||||||||||||||||